Law­mak­ers con­sid­er lim­it­ing how long ex­ist­ing WuXi con­tracts can con­tin­ue

House mem­bers want drug­mak­ers to end their ex­ist­ing con­tracts with WuXi AppTec and oth­er Chi­nese firms by 2032, two sources told End­points News.

The Biose­cure Act, un­der its cur­rent Sen­ate it­er­a­tion, pro­pos­es to es­sen­tial­ly ban pop­u­lar Chi­nese con­trac­tors from ink­ing new US deals. Now, new­ly draft­ed lan­guage would fur­ther crack down on these com­pa­nies by sun­set­ting their con­tracts that are al­ready in progress. A 2032 dead­line, while still years away, would im­pact an in­dus­try that deals in long time­lines.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER